Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
25–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
The subject will have elective total abdominal hysterectomy using a transverse incision with or without bilateral salpingo-oophorectomy. The total hysterectomy may, however, be cervix-sparing.
The subject is expected to remain at the hospital (or intermediate care facility) for a minimum of 2 days following surgery.
The subject's preoperative health is graded as the American Society of Anesthesiologist P1 to P2.
You may not be if
Subjects having vaginal hysterectomy (whether laparoscopically assisted or not)
Subjects having additional procedures (such as those involving the bladder) at the same time as the total abdominal hysterectomy
The use of nerve block, spinal anesthesia or epidural anesthesia for post-surgical pain control
Subjects who have been using any opioid medications 2 weeks or more continuously within 3 months prior to the screening visit.
The subject has taken any NSAID or any analgesic other than acetaminophen within 3 days prior to surgery or is unwilling to abstain from NSAIDs or other analgesics, except as specified in the protocol, during the study. (Subjects taking \<325 mg per day of aspirin at a stable dose for at least 30 days before the first dose of study medication will be allowed to continue their aspirin regimen for the duration of the study).
